{"id":617316,"title":"Explanatory notes for drug establishments on the preparation of a site master file (GUI-0005) - Summary - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T05:33:14.012000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/annex-1-explanatory-notes-industry-preparation-site-master.html","snippet":"Explanatory notes for drug establishments on the preparation of a site master file (GUI-0005) - Summary Related guides and help Explanatory Notes for Pharmaceutical Manufacturers on the Preparation of a Site Master File (SMF) (PE 008-4 ). Site master file (SMF) for source plasma…","rawSnapshotUrl":"/api/snapshots/raw/617316","browseUrl":"https://replay.healtharchive.ca/job-6/20260303053314/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/annex-1-explanatory-notes-industry-preparation-site-master.html#ha_snapshot=617316","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}